Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells

AD Wickenden, A Zou, PK Wagoner… - British journal of …, 2001 - Wiley Online Library
AD Wickenden, A Zou, PK Wagoner, T Jegla
British journal of pharmacology, 2001Wiley Online Library
Heteromeric KCNQ5/Q3 channels were stably expressed in Chinese Hamster ovary cells
and characterized using the whole cell voltage‐clamp technique. KCNQ5/Q3 channels were
activated by the novel anticonvulsant, retigabine (EC50 1.4 μm) by a mechanism that
involved drug‐induced, leftward shifts in the voltage‐dependence of channel activation (−
31.8 mV by 30 μm retigabine). KCNQ5/Q3 channels were inhibited by linopirdine (IC50 7.7
μm) and barium (IC50 0.46 mm), at concentrations similar to those required to inhibit native …
Heteromeric KCNQ5/Q3 channels were stably expressed in Chinese Hamster ovary cells and characterized using the whole cell voltage‐clamp technique. KCNQ5/Q3 channels were activated by the novel anticonvulsant, retigabine (EC50 1.4 μM) by a mechanism that involved drug‐induced, leftward shifts in the voltage‐dependence of channel activation (−31.8 mV by 30 μM retigabine). KCNQ5/Q3 channels were inhibited by linopirdine (IC50 7.7 μM) and barium (IC50 0.46 mM), at concentrations similar to those required to inhibit native M‐currents. These findings identify KCNQ5/Q3 channels as a molecular target for retigabine and raise the possibility that activation of KCNQ5/Q3 channels may be responsible for some of the anti‐convulsant activity of this agent. Furthermore, the sensitivity of KCNQ5/Q3 channels to linopirdine supports the possibility that potassium channels comprised of KCNQ5 and KCNQ3 may make a contribution to native M‐currents.
British Journal of Pharmacology (2001) 132, 381–384; doi:10.1038/sj.bjp.0703861
Wiley Online Library